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Introduction
Essential hypertension (EHTN) and other cardiovascular
diseases (CVD) are associated with progressively
increasing morbidity and mortality across the globe.1
Hypertension affected 26.4% of the adult population in
the world in 2000.2 It is expected to increase to about 60%
from the present figure (from 972 million to 1.56 billion)
by 2025.2 About 7.1 million deaths occur per year globally
due to hypertension.3 Etio-pathogenesis of EHTN
encompasses combined effects of genetic factors and
many environmental risk factors.4Wang et al in December
2008 showed that SNP rs35929607 in Serine Threonine
Kinase 39 (STK 39) gene is associated with raised blood
pressure.5 In this European Genome-wide association
(GWA) study, functional single nucleotide polymorphism
(SNP) rs35929607 provided a more significant association
with hypertension than the other SNPs of this gene (i.e. p=
0.04 for rs35929607, p= 0.09 for rs3754777, and p= 0.12
for rs6749447). The SNP rs35929607 is located in the
intronic region of gene. The SNP consistent with
rs35929607 was regarded as being either a better
surrogate for the functional variant or it is the functional
variant by itself.5 Therefore, we studied the prevalence of
SNP rs35929607, genotypes and allele frequencies and
performed comparative analysis of the effect size of risk
factors in a Pakistani population. 
STK39 contains 18 exons and covers a 293.65 kilo base
region i.e. from 168812426 to 168518776 on the reverse
strand of the gene as reported in National Centre for
Biotechnology Information (NCBI) 36. Chromosomal
location of STK39 is at 2q24.3. Variants of STK39 human
gene produce proteins which influence blood pressure by
increasing STK39 expression and consequently alter renal
sodium excretion. On Affymetrix 100K platform, several
SNPs are found located within 5 kb of STK39.5 This gene
encodes a STK in response to renal tubular cell hypo-
tonicity or low sodium state (i.e. cellular-stress). This leads
to phosphorylation of cation chloride coupled co-
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Abstract
Objective: To study the prevalence of Serine Threonine Kinase-39 A?G polymorphism rs3592960 in rural population.
Methods: The random, cross-sectional study was carried out from 2009 to 2010 on 528 subjects in Tharparkar,
Pakistan. Data was recorded excluding cases of secondary hypertension. Normotensives were used as the controls
and hypertensives as the cases. Genotyping was carried out by tetra-primer amplification refraction mutation
system-polymerase chain reaction method and the data was analysed statistically with SPSS-14. 
Results: The association of Serine Threonine Kinase-39 rs35929607 with essential hypertension was as 3.07 (95%
confidence interval 2.10-4.49) units/mmHg per G allele (p= 0.001). Raised systolic BP >140mmHg showed 0.76 (95%
CI, 0.47-1.23) (p= 0.235) and raised diastolic BP >90mmHg showed 0.93 (95% CI, 0.61-1.44) units/mmHg per G allele
(p= 0.735). Frequency of the risk allele G was less (33.3%) than that of allele-A (66.7%), (p= 0.0001). The effect size of
genetic factors was non-significant, β= 0.062 (p= 0.153) for GG homozygotes and β= -0.013 (p= 0.772) for AG
heterozygotes. Effect size of risk factors (age>50 years, diabetes and body mass index >23) was found significantly
associated with essential hypertension, β= 0.747 (p= 0.000). The risk factors increased the effect by 12.04 fold in GG
genotype and further 3 fold influence of risk factors is required with single allele-G in case of AG heterozygotes. 
Conclusion: Essential hypertension risk conferred by this polymorphism in the study population is different from
the previously reported European population, suggesting that the variant G allele remains less associated in the
absence of environmental risk factors.
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transporters producing activation of p38
Mitogenactivated protein (MAP) kinase pathway. These
mechanisms result in the absorption of sodium and water
to increase intravascular volume and blood pressure.6-9
The presence of the G allele of rs35929607 may increase
the activity of downstream sodium potassium chloride
co-transporter (NKCC2) and sodium chloride
cotransporter (NCC), which would promote Na+ re-
absorption, thereby increasing intravascular volume and
blood pressure.5
Among the various genes attributed to EHTN, some are
more important for the overall blood pressure regulation
mechanism. For example, angiotensin converting enzyme
(ACE) gene, renin (RENIN) gene, angiotensin II receptor 1
(AGTR1) gene and genes involved in the feedback loops of
lipid regulation e.g. apolipoprotein A1 (APOA1) etc. What
is important for the future is to look at definite number of
genetic polymorphisms contributing to genetic variation
depending on both genetic and environmental effects.4
Therefore, SNPs in various genes reflecting the gene
interactions will constitute the most important tools to
clarify the feedback loops that operate to raise the blood
pressure. 
Complex disorders like hypertension, type-2 diabetes
mellitus and atherosclerosis are known to have a
polygenic basis.10Hypertension and dyslipidaemia cluster
more often than any other common cardiovascular
diseases.11 South Asians and US populations exhibit a
higher prevalence of metabolic syndrome.12-15 The
studies of genetic polymorphisms and allelic alterations
explore the genetic attributes of the disease. Present
strategies towards decreasing hypertension and
cardiovascular diseases emphasise awareness and
practice of non-pharmacological interventions, especially
physical activity and exercise.16
Material and Methods
The study was undertaken after approval from the Ethics
Review Committee (ERC) of the Aga Khan University (AKU).
The research area was located at a site far removed from
urban Karachi. The consent form containing information
about potential risks and benefits of participating in the
study was administered and the signature was obtained
from the subjects. In the absence of a signature, a thumb
impression of the participant was obtained. In case of
children, a parent or guardian's signature or thumb
impression was also obtained. AKU ERC approved this
procedure of taking the consent. We employed qualified
physicians who could assess the clinical condition and co-
morbidities and could take good history. We carried out
preliminary visits to research area followed by multiple
trips to get accurate phenotypic data. 
The random cross-sectional study was carried out from
2009 to 2010 on 528 subjects in Tharparkar, Sindh,
Pakistan, which is located at 24° 42' 0" North and 70° 11' 0"
East coordinates. We recruited the subjects by random
selection. The sample size was calculated statistically with
confidence level of 95% by assuming 20% prevalence of
hypertension among the study population; and we also
incorporated 10% design effect in the sample size. We
genotyped 528 subjects compared to the calculated
sample size of 405 subjects to get satisfactory outcome.
The prevalence of genotypes and frequencies of the allele
A and G were calculated. The effect size of genetic factors
was comparatively analysed with the effect size of risk
factors i.e. advanced age (>50 years), presence of
comorbid (diabetes) and raised body mass index (BMI) >23
adjusted to raise the blood pressure. BMI of Asian criteria
was used due to the subjects being of Dravidian race.17
All subjects with a known history of hypertension, newly
diagnosed cases and subjects taking anti-hypertensive
medication were included. All subjects below 7 years were
excluded. The younger population is more exposed to a
sedentary life pattern due to current usage of computer
games and electronic media so hypertension can occur in
paediatric age group as well. We therefore recruited
children above 7 years in the study. 
Subjects with poor compliance for recruitment and non-
compliance in donating blood samples were excluded. A
careful past history was obtained by qualified physicians
to exclude the secondary causes of hypertension e.g.
renal, endocrinological, cortisone-induced and subjects
with diabetes as a predisposing cause of hypertension.
Hypertensive subjects were also assessed for presence of
its complications and other associated comorbids (i.e.
stroke, ischaemic heart disease and development of
diabetes mellitus after the onset of hypertension etc.)
Anthropometric and demographic data were recorded for
each subject. Three blood pressure measurements were
taken from the left arm at 15-minute intervals in the
resting state from each individual. Any individual with
systolic blood pressure >140mmHg and diastolic blood
pressure >90mmHg on all the three occasions was
diagnosed as hypertensive. Hypertensive subjects were
designated as the cases, while normotensives as the
controls. 
Blood samples were collected in tubes containing
ethylenediaminetetra acetic acid (EDTA) and stored at 4°C
immediately. 
Deoxyribonucleic acid (DNA) was extracted from the
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whole blood by phenol-chloroform-isoamyl alcohol
method (Centre for Cell and Gene Therapy, Vector
Development Lab., Texas, USA). FASTA sequence showing
point mutation in STK39 gene at SNP rs35929607 was
obtained from the NCBI website.18 Primers were designed
for tetra primers amplification refraction mutation
system-polymerase chain reaction (ARMS-PCR) method
by using the software http://cedar.genetics.soton.ac.uk/
public_html/primer1.html.19 (viz. inner forward CTC ATG
GAA TTA AAG GAT TAT TAG GAT AAC G Mer31, Outer
forward AAC ACT CTC ACA AGA AGA GAT CCC AGT G
Mer28, Inner reverse CAC ATT TTG GCA GTG TTT GGA CAG
CT Mer26, Outer reverse CTC CCA GGT CGT TTT CAA ACA
AAA ATA A Mer28).
All subjects were genotyped with 100% quality controls
and we got accurate results. In order to detect allele A, we
used tetra primer ARMS-PCR reaction. The detection of
the allele G was carried out by using ARMS PCR reaction.
PCR was carried out using an Eppendorf Gradient
Thermocycler. The reaction mix was incubated and the
following programme was used: 95°C for 7 minutes (initial
denaturation); 95°C for 45 seconds (denaturation, 44
cycles); 66°C for 45 seconds (annealing, 44 cycles); 72°C for
45 seconds (extension, 44 cycles); 72°C for 7 minutes (Final
extension) and 4°C (hold phase).
The PCR products were separated by 2.5% agarose gel
electrophoresis run at 120V for 30 to 40 minutes, and the
gel was transferred to Gel Doc (BioRad) for visualisation
under ultraviolet light. Bands for the required product
sizes were obtained (i.e. outer primers 349bp, allele-A
175bp and allele-G 231bp). 
Data was analysed statistically for prevalence of individual
homozygous i.e. AA and GG genotypes, and heterozygous
AG genotypes, frequencies of alleles A and G and
comparative analysis of effect size of genetic versus risk
factors. Assessment for concordance with Hardy
Weinberg Equilibrium (HWE) was performed. Chi-square
and odds ratio with 95% confidence limitation for
frequencies of allele A and allele G was calculated.
Statistical softwares used for these analyses were SPSS 14,
Microsoft Excel and Epi-Info 1.1. 
Results
Of the total, 273 (52%) were males, and 255 (49%) females.
All subjects were genotyped for STK39 SNP. The mean age
of the subjects was 37.08±16.42 years. 
Genotype frequencies were found to be 191 (36.2%) for
AA; 322 (61.0%) for AG; and 15 (2.8%) for GG. Frequency of
reference allele (A) was 704 (66.7%) and of rare allele (G)
was 352 (33.3%) (χ2 = 73.1 and P= 0.0001) (Table-1). A
sanity check indicated that the population did not fall in
concordance with HWE and it deviated from the right
population structure and appeared to be stratified,
signifying the fact that there were hypertensive
phenotypes present in it. The controls were also tested for
HWE which also showed a similar pattern. 
Significant differences in the distribution of three
genotypes according to clinical phenotype were
observed (Table-2). Occurrence of AG genotype was
found higher in the majority of subjects (59% [n=44] in
hypertensive subjects; 64% [n=27] in subjects with raised
systolic BP; 59% [n=33] in raised diastolic BP; 59% [n=162]
in males and 63% [n=160] in females). Subjects who
became diabetic had 57% (n=19) occurrence of AG
genotype. Phenotypes which differed and did not fall in
HWE were the presence of hypertension (p= 0.008),
asthma (p= 0.01), systolic BP >140mmHg (p= 0.02) and
diastolic BP >90mmHg (p= 0.02). Such deviations are to
be expected when there is a marked association with the
clinical phenotype, especially in homogenous
populations. The diabetic subjects showed a borderline
value for falling in HWE (p= 0.06). 
The odds ratio of STK39 rs35929607 with essential
hypertension was 3.07 (95% confidence interval 2.10-4.49)
units/mmHg per G allele (p= 0.000) (Table-3). Association
of STK39 rs35929607 polymorphism with raised systolic BP
>140 was 0.76 (95% CI 0.47-1.23) units/mmHg per G allele
(p= 0.235). Association of STK39 rs35929607
polymorphism with raised diastolic BP >90mmHg was 0.93
(95% CI 0.61-1.44) units/mmHg per G allele (p= 0.735).
Frequency of allele G was less (i.e. 33.3%) than that of allele
A (66.7%), (p= 0.0000). Frequency of allele G was also non-
significantly associated with hypertensive subjects which
later on became diabetic [Odds ratio 1.08; 95% CI, 0.61-
1.90, (p= 0.787) units per G allele]. 
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Table-1: Statistical genotype frequencies, allele frequencies and Hardy Weinberg
Equilibrium analysis of the studied population.*
Genotype Observed number Genotype frequency
11 191 0.362
12 322 0.610
22 15 0.028
Total Genotyped 528
Allele Observed number Allele frequency
1 704 0.667
2 352 0.333
Total 1056
χ2 73.129
p-value* < 0.0001
* Sanity check indicating the subjects of selected population (n = 528) deviated from HWE.
1: allele-A, 2: allele-G.
The effect size of genetic factors was tested and
compared with the effect size of the risk factors (i.e.
advanced age >50 years, presence of diabetes and BMI
>23) adjusted to raise blood pressure. The blood pressure
raising effect due to risk factors was found to be highly
significant in GG homozygotes i.e. β= 0.747 (p= 0.001).
This effect is 1.6 fold higher than the risk factor effect of
single allele (i.e. allele G in AG heterozygotes, β= 0.469 (p=
0.000). In contrast, the effect size due to genetic factors
alone in these patients was found to be non-significant i.e.
β= 0.062 (p= 0.153) for GG homozygotes and β= -0.013
(p= 0.772) for AG heterozygotes (Table-4). Similar findings
were obtained in case of analyses carried out for isolated
raised systolic (BP>140) and raised diastolic blood
pressure (BP>90). The risk factors increased the effect by
12.04 fold in GG genotype and the risk factors need to be
3 times higher to create significant effect in the presence
of single G allele in case of AG genotype.
The effect size of the risk factors was further looked for the
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Table-2: Genotypes, allele frequencies and χ2 to show significance of variables with Hardy Weinberg Equilibrium (HWE).
Basic Characteristics Genotype Frequencies Alleles Frequencies χ2 p-value
AA, n (%) AG, n (%) GG, n (%) A, n (%) G, n (%)
Males ¤ 102 (37) 162 (59) 9 (3.3) 366 (67) 180 (33) 32.0 0.0001
Females ¤ 89 (35) 160 (63) 5 (2.0) 338 (66) 170 (33) 43.6 0.0001
Hypertensives 26 (35) 44 (59) 4 (5.4) 96 (64) 52 (35) 6.8 0.008
Nonhypertensives 165 (36) 11 (2.4) 278 (61) 341 (37) 567 (62) 408.0 0.0001
Diabetics ¤ 13 (39) 19 (57) 1 (3.0) 45 (68) 21 (31) 3.5 0.06*
Non-diabetic ¤ 177 (36) 301 (61) 14 (2.8) 655 (66) 329 (33) 68.9 0.0001
Asthmatics ¤ 21 (37) 33 (58) 2 (3.6) 75 (67) 37 (33) 6.1 0.01
Non-asthmatics ¤ 168 (36) 13 (2.8) 285 (61) 349 (37) 583 (62) 412.1 0.0001
SBP<140mmHg ¤ 175 (36) 290 (60) 12 (2.5) 640 (67) 314 (32) 67.6 0.0001
SBP>140mmHg ¤ 12 (28) 27 (64) 3 (7.1) 51 (60) 33 (39) 5.07 0.02
DBP<90mmHg ¤ 167 (36) 283 (61) 12 (2.6) 617 (66) 307 (33) 66.8 0.0001
DBP>90mmHg ¤ 20 (35) 33 (59) 3 (5.4) 73 (65) 39 (34) 4.9 0.02
n: observed number, SBP: systolic blood pressure, DBP: diastolic blood pressure; *Falling in concordance with HWE. ¤: Missing values for both genders (1), diabetics and non-diabetics (3), asthmatics and non-
asthmatics (6), systolic BP (9) and diastolic BP (10).
Table-3: Logistic regression determinants of main variables with frequencies of allele A and allele G.
Alleles Comparative frequencies of cases O R 95% CI χ2 p-value
Hypertensive Normotensive Sum
Allele- A 96 341 437
Allele - G 52 567 619
148 908 1056 3.07 2.10 – 4.49 39.1 0
Diabetics Non-diabetics Sum
Allele- A 45 655 700
Allele - G 21 329 350
66 984 1050 1.08 0.61 – 1.90 0.07 0.787
Asthmatics Non-asthmatics Sum
Allele- A 75 349 424
Allele - G 37 583 620
112 932 1044 3.39 2.19 – 5.24 36.12 0
SBP>140mmHg SBP<140mmHg Sum
Allele- A 51 640 691
Allele - G 33 314 347
84 954 1038 0.76 0.47 – 1.23 1.41 0.235
DBP>90mmHg DBP<90mmHg Sum
Allele- A 73 617 690
Allele - G 39 307 346
112 924 1036 0.93 0.61 – 1.44 0.11 0.735
OR: Odds Ratio, SBP: systolic blood pressure, DBP: diastolic blood pressure.
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Table-4: Comparative analysis of effect size of STK39 variant rs35929607 with the effect size of risk factors.
Subject's Phenotype Model β-value* 95% Confidence Limit p-value
Hypertensives BP>140/90mmHg (Both SBP & DBP raised) GG-genotype
M1 0.062 -0.097, 0.618 0.153
M2 0.328 0.352, 0.642 0.000
M3 0.564 0.583, 10.043 0.000
M4 0.291 -0.432, -0.208 0.000
M5 0.747 0.104, 0.216 0.000
Hypertensives BP>140/90mmHg (Both SBP & DBP raised) AG-genotype
M1 -0.013 -070, 0.052 0.772
M2 0.257 0.360, 0.650 0.000
M3 0.542 0.579, 10.040 0.000
M4 0.214 -0.427, -0.203 0.000
M5 0.469 0.102, 0.213 0.000
Normotensives BP<140/90mmHg (Both SBP & DBP normal) GG-genotype
M1 -0.062 -0.309, 0.048 0.153
M2 -0.328 -0.321, -0.176 0.000
M3 -0.564 -0.521, -0.291 0.000
M4 -0.292 0.104, 0.216 0.000
M5 -0.747 -0.108, -0.052 0.000
Normotensives BP<140/90mmHg (Both SBP & DBP normal) AG-genotype
M1 0.013 -0.026, 0.035 0.772
M2 -0.257 -0.325, -0.180 0.000
M3 -0.498 -0.520, -0.290 0.000
M4 -0.214 0.102, 0.213 0.000
M5 -0.662 -0.107, -0.051 0.000
Raised SBP(>140mmHg) GG-genotype
M1 0.075 -0.035, 0.526 0.086
M2 0.385 0.340, 0.565 0.000
M3 0.469 0.041, 0.411 0.017
M4 0.390 -0.182, 0.001 0.052
M5 0.556 0.000, 0.091 0.052
Raised SBP(>140mmHg) AG-genotype
M1 0.020 -0.037, 0.059 0.657
M2 0.333 0.344, 0.569 0.000
M3 0.419 0.040, 0.410 0.017
M4 0.340 -0.177, 0.005 0.065
M5 0.488 -0.003, 0.089 0.065
Raised DBP(>90mmHg) GG-genotype
M1 0.051 -0.131, 0.509 0.246
M2 0.253 0.204, 0.469 0.000
M3 0.296 -0.087, 0.351 0.238
M4 0.117 -0.301, -0.082 0.001
M5 0.421 0.041, 0.150 0.001
Raised DBP(>90mmHg) AG-genotype
M1 -0.015 -0.064, 0.046 0.737
M2 0.191 0.210, 0.475 0.000
M3 0.234 -0.090, 0.348 0.249
M4 0.055 -0.298, -0.079 0.001
M5 0.353 0.039, 0.149 0.001
Normal SBP(<140mmHg) GG-genotype
M1 -0.075 -0.263, 0.018 0.086
M2 0.385 -0.282, -0.170 0.000
M3 0.469 -0.205, -0.020 0.017
M4 -0.390 0.000, 0.091 0.052
M5 0.556 -0.045, 0.000 0.052
one causing most profound rise of blood pressure. It was
found that the most significant effect was due to BMI>23
followed by diabetes and advanced age (β= 0.747, 0.564,
0.328 respectively in case of GG homozygotes). 
Discussion 
Essential hypertension (EHTN) is a known complex
multifactorial disorder in which genetic and
environmental risk factors play a part in etio-
pathogenesis.20 Prevalence of hypertension varies from
region to region throughout the world. It is lowest in the
Indo-Pak subcontinent (India, 3.4% in men and 6.8% in
women) and the highest in Poland (68.9% in men and
72.5% in women).21 Coronary artery disease is also a
notable cause of morbidity and mortality in the US
(specially African-Americans) and South Asians.22-24 The
mortality rates from coronary artery disease in South Asians
are reported to be two to three times higher than those in
Caucasians irrespective of gender, religion, social class,
dietary practices or the country of residence.24 In Pakistan,
prevalence of EHTN is found to be 22.7% (as obtained from
the WHO website i.e. Info Base: All data, Pakistan). The
presently studied population from Tharparkar, Pakistan,
showed prevalence of EHTN to be 14.3%. 
In a European study carried out in 2009, the STK39 gene
SNP rs35929607 were coincidently associated
significantly with systolic and diastolic blood pressure, (p
<0.05).5 In the present study, we found an insignificant
association of this polymorphism with EHTN (p= 0.153).
We looked at the prevalence of STK39 SNP and observed
the prevalence of frequencies of reference and rare alleles
and also observed the concordance with HWE. 
STK39 locus lies within a genomic region in which
multiple blood pressure, obesity, and diabetes-related
rodent quantitative trait loci have been mapped. This
close proximity of the EHTN, obesity and diabetes-related
loci may explain the tendency of hypertensive subjects to
develop diabetes.25 Individuals with an inherent genetic
susceptibility to develop EHTN when exposed to the
hypertension-inducing risk factors develop the onset and
progression of the disease. Hence, minimising these risk
factors will tend to prevent such onset and complications
of EHTN. Studies have shown that physical activity and
exercise decrease blood pressure in about 75% of
hypertensive individuals.24 With exercise, patients also
improve other important parametres like lipoproteins and
lipid levels as well as insulin sensitivity.24
The variant allele AG which is characteristic of this SNP
ideally showed a high prevalence of the genotype AG to
be associated with EHTN. The reference allele A showed
higher frequency than the rare allele G (p 0.0001). These
findings highlight the weaker association of STK39 gene
with EHTN in the study population. It is anticipated that in
this case, the environmental risk factors might have
played a predominant role in increasing the blood
pressure. 
We confirmed the significance of the effect size of the
environmental risk factors after adjusting for raised
systolic and diastolic blood pressure. We found that the
effect size increased with addition of tested risk factor (i.e.
advanced age, diabetes and raised BMI). With the low BMI
(<23), the β-value was less (i.e. 0.291), but its value was
found to drastically increase with high levels of BMI (>23)
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Normal SBP(<140mmHg) AG-genotype
M1 -0.020 -0.030, 0.019 0.657
M2 -0.333 -0.285, -0.172 0.000
M3 0.419 -0.205, -0.020 0.017
M4 0.340 -0.003, 0.089 0.065
M5 0.498 -0.044, 0.001 0.065
Normal DBP(<90mmHg) GG-genotype
M1 -0.051 -0.255, 0.065 0.246
M2 -0.253 -0.235, -0.102 0.000
M3 -0.296 -0.175, 0.044 0.238
M4 -0.117 0.041, 0.150 0.001
M5 -0.291 -0.075, -0.020 0.001
Normal DBP(<90mmHg) AG-genotype
M1 0.015 -0.023, 0.032 0.737
M2 -0.191 -0.238, -0.105 0.000
M3 -0.234 -0.174, 0.045 0.249
M4 -0.055 0.039, 0.149 0.001
M5 -0.353 -0.074, -0.020 0.001
M (Model) 1= Effect size due to alleles only (i.e. GG or AG respectively), M2= Alleles GG or AG + Age>50 years M3= Alleles GG or AG + Age>50 years + diabetes, M4= Alleles GG or AG + Age >50 years +
diabetes + BMI<23 (Asian Criteria), M5= Alleles GG or AG + Age>50 years +diabetes + BMI>23 (Asian Criteria).
SBP=Systolic blood pressure, DBP=Diastolic blood pressure. *= Cohen's rule (?-values of 0.2-0.3 shows small effect, 0.4-0.5 medium effect and 0.6-0.8 large effect).
to 0.747 in hypertensive phenotype. In case of the
normotensives with GG homozygotes, though the β-
value came out to be high, it gave an insignificant p value
for all the tested risk factors except age>50 years. This
showed that GG homozygote individuals, though they
show a normal phenotype, are showing tendency to be
hypertensive on addition of risk factors. We also report
that the analyses carried out separately for the male and
female genders revealed similar pattern of the effect size
of genetic and risk factors. 
Linear and logistic regression analyses showed that the
main blood pressure raising effect was found to be due to
BMI which itself is regulated by discrete genes implicated
in its control. BMI was also found to follow a rising trend
with advancing age, but age itself was an independent
factor separate from BMI in this study. In the light of this,
age factor may be ruled out, but BMI could be deemed as
the most significant factor which in turn is to be impacted
by discrete set of its own regulating genes. 
An aggressive management of the raised BMI,
dyslipidaemia and hypertension is, therefore, warranted
to lower the risks of EHTN and cardiovascular disease.
Future research should focus on the development of
inexpensive and efficient systems to improve blood
pressure and lipid profiles. 
Conclusions
In this study, essential hypertension risk conferred by
STK39 rs35929607 polymorphism (A/G) was different
from the previously reported European Population,
suggesting that the underlying variant G allele in
heterozygotes in the Pakistani population remain
unidentified (less associated) in the absence of the risk
factors. Interaction of the genetic and environmental risk
factors was essential for significant association of GG
homozygous alleles in the study population.
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